(b) On July 11, 2019, Intuitive Surgical, Inc. (the “Company”) announced that Salvatore J. Brogna will transition from his role as Executive Vice President and Chief Operating Officer in 2019 and plans to serve as a consultant and advisor to the Company starting in 2020 on terms and conditions to be agreed between the Company and Mr. Brogna.

Item 7.01. Regulation FD.

A copy of the press release announcing the transition of Mr. Brogna is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

>

INTUITIVE SURGICAL INC Exhibit
EX-99.1 2 ex991pressrelease-salbrogn.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Intuitive Announces Transition of Chief Operating Officer Sal Brogna after Two Decades of ServiceSUNNYVALE,…
To view the full exhibit click here

About INTUITIVE SURGICAL, INC. (NASDAQ:ISRG)

Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation solution and three-dimensional (3-D), high-definition vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. It focuses on five surgical specialties: gynecologic surgery, urologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.